Line
Alnylam Pharmaceuticals: operating cash flow and capital expenditure
Trailing twelve months, $ billions, from SEC filings
Plays the chart through its history. Pauses are where the data set a record or moved most.
Palanor Foresight™ comes with a free Palanor account. Create one · Continuation is open to everyone.
What this chart reads
- Operating cash flowlatest 2025-12-31
- Capital expenditurelatest 2025-12-31
Sources
Operating cash flow. Source: SEC EDGAR.
Capital expenditure. Source: SEC EDGAR.
Charts are drawn from Palanor's signal library and recomputed from source data on every view. Transformations (changes, indexing, year-on-year rates) are Palanor's.